Ilsung Pharm (003120) — Capital Reinvestment Ratio
Ilsung Pharm (003120) has a Capital Reinvestment Ratio of 0.08x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩5.13 Billion) in capital expenditures (₩395.62 Million). Check Ilsung Pharm tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ilsung Pharm Capital Reinvestment Ratio (2013–2025)
This chart tracks Ilsung Pharm's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Ilsung Pharm.
Annual Capital Reinvestment Ratio for Ilsung Pharm (2013–2025)
Year-by-year Capital Reinvestment Ratio for Ilsung Pharm from 2013 to 2025. See 003120 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.56x | ₩3.88 Billion | ₩2.18 Billion | ▼ -70.7% |
| 2021 | 1.92x | ₩5.70 Billion | ₩10.93 Billion | ▼ -38.1% |
| 2020 | 3.09x | ₩1.56 Billion | ₩4.82 Billion | ▲ +994.5% |
| 2019 | 0.28x | ₩4.39 Billion | ₩1.24 Billion | ▲ +252.7% |
| 2018 | 0.08x | ₩15.09 Billion | ₩1.21 Billion | ▼ -56.0% |
| 2017 | 0.18x | ₩10.16 Billion | ₩1.85 Billion | ▼ -61.4% |
| 2015 | 0.47x | ₩6.04 Billion | ₩2.85 Billion | ▲ +109.0% |
| 2014 | 0.23x | ₩4.19 Billion | ₩945.31 Million | ▲ +1.4% |
| 2013 | 0.22x | ₩5.06 Billion | ₩1.13 Billion | — |